Century Therapeutics, Inc.IPSCNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR-61.4%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
-61.4%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
20255.05%
2024-8.04%
2023-516.75%
202287.65%
2021-162.21%
2020-174.29%
20190.00%